A comprehensive view of National Institutes of Health (NIH). This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Exposure to chemicals among pregnant women has increased significantly in the last decade, according to NIH-funded study; urine tests evaluated exposure to more than 100 chemicals, including new substances introduced to replace dangerous chemicals
Published: June 06, 2022 by University of Michigan
Institute for Molecular Medicine gets US$12M grant from NIH for Phase 1 clinical trial of beta-amyloid vaccines based on DNA, recombinant protein to prevent Alzheimer’s disease; Q2 trial to use PharmaJet’s Tropis needle-free injection system
Published: June 01, 2022 by Business Wire
US National Institutes of Health awards US$577M to create research centers to develop antivirals for COVID-19, other viruses with high potential to cause future pandemics; centers to develop biotherapeutics that block viral targets
Published: May 24, 2022 by SeeNews Pharmaceuticals
NIH deciding whether to extend course of Pfizer’s oral Paxlovid to 10-days to prevent COVID-19 recurrence; over 660,000 courses of Paxlovid administered in US, with reinfections not affecting Paxlovid’s effectiveness against hospitalization, death
Published: May 19, 2022 by Reuters
Pregnant women are exposed to rising levels of certain chemicals, particularly alternate chemicals meant to replace banned substances, according to NIH-funded study; many had been exposed to neonicotinoids, a widely used type of pesticide
Published: May 11, 2022 by PR Newswire

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count